| Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label … L Paz-Ares, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet 394 (10212), 1929-1939, 2019 | 1539 | 2019 |
| Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN … JW Goldman, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet Oncology 22 (1), 51-65, 2021 | 436 | 2021 |
| Severe vascular toxicity associated with cisplatin‐based chemotherapy F İçli, H Karaoǧuz, D Dinçol, A Demirkazik, N Günel, R Karaoǧuz, A Üner Cancer 72 (2), 587-593, 1993 | 167 | 1993 |
| Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer F Icli, H Akbulut, G Utkan, B Yalcin, D Dincol, A Isikdogan, A Demirkazik, ... Journal of surgical oncology 95 (6), 507-512, 2007 | 133 | 2007 |
| Lume-lung 2: A multicenter, randomized, double-blind, phase III study of nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with advanced nonsquamous non … NH Hanna, R Kaiser, RN Sullivan, OR Aren, MJ Ahn, B Tiangco, ... Journal of Clinical Oncology 31 (15_suppl), 8034-8034, 2013 | 102 | 2013 |
| Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey Y Urun, G Utkan, AK Cangir, OB Oksuzoglu, N Ozdemir, DG Oztuna, ... Asian Pacific Journal of Cancer Prevention 14 (5), 2801-2803, 2013 | 61 | 2013 |
| A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5‐fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma F İçli, İ Çelik, F Aykan, A Üner, A Demirkazik, A Özet, M Özgüroǧlu, F Taş, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 54 | 1998 |
| ABO and Rh blood groups and risk of colorectal adenocarcinoma Y Ürün, N Ozdemir, G Utkan, H Akbulut, B Savaş, B Oksuzoglu, D Öztuna, ... Asian Pacific Journal of Cancer Prevention 13 (12), 2012 | 37 | 2012 |
| The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey). A Yorgancioğlu, H Türktaş, O Kalayci, N Yardim, T Buzgan, A Kocabaş, ... Tuberkuloz ve Toraks 57 (4), 439-452, 2009 | 36 | 2009 |
| Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation A Demirkazik, A Kessinger, JO Armitage, PJ Bierman, J Lynch, J Vose, ... Bone marrow transplantation 28 (2), 207-212, 2001 | 36 | 2001 |
| Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin’s lymphomas in Turkey A Arcan, D Dinçol, H Akbulut, H Onur, A Demirkazk, F Çay, F Içli American journal of clinical oncology 22 (6), 587, 1999 | 35 | 1999 |
| Modification and Implementation of NCCN Guidelines™ on Non–Small Cell Lung Cancer in the Middle East and North Africa Region AR Jazieh, H Bamefleh, A Demirkazik, RM Gaafar, FB Geara, M Javaid, ... Journal of the National Comprehensive Cancer Network 8 (Suppl_3), S-16-S-21, 2010 | 34 | 2010 |
| Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: the introduction of a novel alternative palliative therapy … B Cakir, O Topaloglu, K Gul, T Agac, C Aydin, A Dirikoc, RU Ersoy, ... Journal of endocrinological investigation 30, 624-625, 2007 | 34 | 2007 |
| Tuberculous peritonitis: ultrasonic diagnosis O Akhan, FB Demirkazik, A Demirkazik, N Gülekon, M Eryllmaz, M Unsal, ... Journal of clinical ultrasound 18 (9), 711-714, 1990 | 33 | 1990 |
| Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer C Atalay, A Demirkazik, U Gunduz Journal of chemotherapy 20 (6), 734-739, 2008 | 32 | 2008 |
| Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III … F Icli, H Akbulut, A Uner, B Yalcin, E Baltali, M Altinbas, Ş Coşkun, ... British journal of cancer 92 (4), 639-644, 2005 | 32 | 2005 |
| The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer Y Ürün, G Utkan, B Yalcin, H Akbulut, H Onur, DG Oztuna, FÇ Şenler, ... Experimental oncology, 2015 | 30 | 2015 |
| Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members Y Urun, H Akbulut, A Demirkazik, FC Senler, G Utkan, H Onur, F Icli Age 57, 18-90, 2013 | 28 | 2013 |
| GLASS: Global Lorlatinib for ALK (+) and ROS1 (+) retrospective Study: real world data of 123 NSCLC patients N Peled, R Gillis, S Kilickap, P Froesch, S Orlov, E Filippova, U Demirci, ... Lung Cancer 148, 48-54, 2020 | 27 | 2020 |
| Venous thromboembolism in patients with cancer and its relationship to the coagulation cascade and vascular endothelial growth factor M Dogan, A Demirkazik Supportive cancer therapy 3 (1), 28-34, 2005 | 27 | 2005 |
